NX-1607 clinical trials

A Study of NX-1607 in Adults With Advanced Malignancies

This study is looking into a new treatment called NX-1607 for various advanced cancers, including ovarian, stomach, and lung cancer. It aims to see how safe the treatment is and if it can help fight the cancer, sometimes combined with another drug called Paclitaxel.